|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
N/A |
Shares
Out: |
26,519,000 |
Market
Cap: |
19.28(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.55 - $1.72 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile VolitionRx is an epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop blood tests to help diagnose and monitor a range of life-altering diseases including certain cancers and diseases associated with NETosis such as sepsis and COVID-19. Co.'s tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Co. is primarily focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
40,000 |
210,422 |
928,911 |
Total Buy Value |
$0 |
$28,700 |
$210,662 |
$1,588,869 |
Total People Bought |
0 |
3 |
11 |
12 |
Total Buy Transactions |
0 |
4 |
21 |
37 |
Total Shares Sold |
0 |
40,000 |
40,000 |
54,949 |
Total Sell Value |
$0 |
$33,000 |
$33,000 |
$69,924 |
Total People Sold |
0 |
1 |
1 |
2 |
Total Sell Transactions |
0 |
2 |
2 |
3 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Hughes Terig |
Chief Financial Officer |
|
2022-10-04 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
130,740 |
|
- |
|
Micallef Jacob Vincent |
Chief Scientific Officer |
|
2022-09-19 |
4 |
B |
$1.70 |
$22,100 |
I/I |
13,000 |
35,000 |
0.01 |
- |
|
Batchelor Ann-Louise |
Group Chief Marketing Officer |
|
2022-09-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
29,406 |
|
- |
|
Batchelor Ann-Louise |
Group Chief Marketing Officer |
|
2022-09-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
18,908 |
|
- |
|
Reynolds Cameron John |
President and CEO |
|
2022-08-30 |
4 |
B |
$1.61 |
$5,635 |
D/D |
3,500 |
1,195,518 |
0.01 |
- |
|
Micallef Jacob Vincent |
Chief Scientific Officer |
|
2022-08-26 |
4 |
B |
$1.74 |
$50,460 |
D/D |
29,000 |
149,228 |
0.01 |
- |
|
Butera Salvatore Thomas |
CEO - Volition Veterinary |
|
2022-08-23 |
4 |
B |
$1.60 |
$8,000 |
D/D |
5,000 |
165,000 |
0.01 |
- |
|
Butera Salvatore Thomas |
CEO - Volition Veterinary |
|
2022-08-22 |
4 |
B |
$1.64 |
$8,200 |
D/D |
5,000 |
160,000 |
0.01 |
- |
|
Henshall Mickie |
|
|
2022-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
|
- |
|
Forterre Gael |
Chief Commerical Officer |
|
2022-08-03 |
4 |
D |
$1.97 |
$7,088 |
D/D |
(3,598) |
65,375 |
|
- |
|
Terrell Jason Bradley Md |
Chief Medical Officer |
|
2022-08-03 |
4 |
D |
$1.97 |
$796 |
I/I |
(404) |
2,326 |
|
- |
|
Terrell Jason Bradley Md |
Chief Medical Officer |
|
2022-08-03 |
4 |
D |
$1.97 |
$8,430 |
D/D |
(4,279) |
30,866 |
|
- |
|
Micallef Jacob Vincent |
Chief Scientific Officer |
|
2022-08-03 |
4 |
D |
$1.97 |
$9,505 |
D/D |
(4,825) |
120,228 |
|
- |
|
Faulkes Martin Charles |
|
|
2022-08-03 |
4 |
D |
$1.97 |
$9,505 |
D/D |
(4,825) |
1,525,243 |
|
- |
|
Innes Guy Archibald |
|
|
2022-08-02 |
4 |
B |
$2.00 |
$600,000 |
I/I |
300,000 |
75,000 |
0.01 |
- |
|
Innes Guy Archibald |
|
|
2022-08-02 |
4 |
B |
$2.00 |
$25,000 |
D/D |
12,500 |
1,562,161 |
0.01 |
- |
|
Gaetan Michel |
Chief Operating Officer |
|
2022-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
25,876 |
40,880 |
|
- |
|
Forterre Gael |
Chief Commerical Officer |
|
2022-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
13,308 |
68,973 |
|
- |
|
Innes Guy Archibald |
|
|
2022-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,046 |
1,549,661 |
|
- |
|
Futcher Edward |
|
|
2022-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,046 |
42,936 |
|
- |
|
Nguyen Kim |
|
|
2022-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,046 |
22,186 |
|
- |
|
Rootsaert Rodney Gerard |
Secretary |
|
2022-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
13,068 |
40,502 |
|
- |
|
Hughes Terig |
Chief Financial Officer |
|
2022-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
19,981 |
30,740 |
|
- |
|
Brudnick Richard |
|
|
2022-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,046 |
19,686 |
|
- |
|
Faulkes Martin Charles |
|
|
2022-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
15,682 |
1,530,068 |
|
- |
|
306 Records found
|
|
Page 6 of 13 |
|
|